Efficacy of derazantinib in intrahepatic cholangiocarcinoma patients with FGFR2 mutations or amplifications: Interim results from the phase 2 study FIDES-01

被引：27
|
作者：
Javle, Milind M.
Abou-Alfa, Ghassan K.
Macarulla, Teresa
Personeni, Nicola
Adeva, Jorge
Bergamo, Francesca
Malka, David
Vogel, Arndt
Knox, Jennifer J.
Evans, T. R. Jeffry
Dimova-Dobreva, Miryana
Harris, William Proctor
Saulay, Mikael
Engelhardt, Marc
Braun, Stephan
Busset, Michele Droz Dit
Borad, Mitesh J.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Cornell Univ, Dept Med, Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[4] Hosp Univ Vall dHebron, Barcelona, Spain
[5] Ist Clin Humanitas, Humanitas Canc Ctr, Rozzano, Italy
[6] Hosp Univ 12 Octubre, Madrid, Spain
[7] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Oncol 1, Padua, Italy
[8] Univ Paris Saclay, Dept Med Oncol, Gustave Roussy, Villejuif, France
[9] Hannover Med Sch, Hannover, Germany
[10] Univ Hlth Network, Wallace McCain Ctr Pancreat Canc, Princess Margaret Canc Ctr, Toronto, ON, Canada
[11] Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[12] Basilea Pharmaceut Int Ltd, Basel, NJ, Switzerland
[13] Univ Washington, Seattle Canc Care Alliance SCCA, Seattle, WA 98195 USA
[14] Natl Inst Canc, Dept Hepatopancreatobiliary Surg & Liver Transpla, Milan, Italy
[15] Mayo Clin, Ctr Canc, Scottsdale, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
427
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Impact of FGFR2 gene fusions on survival of patients with intrahepatic cholangiocarcinoma following curative intent resection
    Buckarma, EeeLN
    De La Cruz, Gabriel
    Truty, Mark
    Nagorney, David
    Cleary, Sean
    Kendrick, Michael
    Borad, Mitesh
    Graham, Rondell P.
    Gores, Gregory
    Smoot, Rory
    HPB, 2022, 24 (10) : 1748 - 1756
  • [32] Expansion part of phase I study of E7090 in patients with cholangiocarcinoma harboring FGFR2 gene fusion and with gastric cancer harboring FGFR2 gene amplification or FGFR2 protein high expression
    Morizane, Chigusa
    Ueno, Makoto
    Ioka, Tatsuya
    Tajika, Masahiro
    Ikeda, Masafumi
    Yamaguchi, Kensei
    Hara, Hiroki
    Yabusaki, Hiroshi
    Miyamoto, Atsushi
    Iwasa, Satoru
    Muto, Manabu
    Takashima, Tsutomu
    Minashi, Keiko
    Komatsu, Yoshito
    Nishina, Tomohiro
    Nakajima, Takako Eguchi
    Sahara, Takatoshi
    Funasaka, Setsuo
    Yashiro, Masakazu
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [33] Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
    Daniela Sia
    Bojan Losic
    Agrin Moeini
    Laia Cabellos
    Ke Hao
    Kate Revill
    Dennis Bonal
    Oriana Miltiadous
    Zhongyang Zhang
    Yujin Hoshida
    Helena Cornella
    Mireia Castillo-Martin
    Roser Pinyol
    Yumi Kasai
    Sasan Roayaie
    Swan N. Thung
    Josep Fuster
    Myron E. Schwartz
    Samuel Waxman
    Carlos Cordon-Cardo
    Eric Schadt
    Vincenzo Mazzaferro
    Josep M. Llovet
    Nature Communications, 6
  • [34] Efficacy and safety of derazantinib (DZB) in patients with metastatic urothelial carcinoma (mUC) with activating FGFR1/2/3 genetic aberrations (GA): Results from the phase 1b/2 FIDES-02 study.
    Necchi, Andrea
    Todenhoefer, Tilman
    Deville, Jean-Laurent
    Haeckl, Manuel
    Marszewska, Michalina
    McKernan, Phil
    Saulay, Mikael
    Engelhardt, Marc
    De Santis, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [35] Efficacy, safety, and quality of life (QoL) with futibatinib in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements: FOENIX-CCA2
    Furuse, J.
    Goyal, L.
    Meric-Bernstam, F.
    Hollebecque, A.
    Valle, J. W.
    Morizane, C.
    Karasic, T. B.
    Abrams, T. A.
    Kelley, R. K.
    Cassier, P. A.
    Klumpen, H-J.
    Uboha, N.
    Mahipal, A.
    Mitchell, E.
    Ahn, E.
    Chang, H-M.
    Masuda, K.
    He, Y.
    Benhadji, K. A.
    Bridgewater, J. A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1288 - S1289
  • [36] FOENIX-101: A phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements.
    Goyal, Lipika
    Bahleda, Rastilav
    Furuse, Junji
    Valle, Juan W.
    Moehler, Markus Hermann
    Oh, Do-Youn
    Chang, Heung-Moon
    Kelley, Robin Kate
    Javle, Milind M.
    Borad, Mitesh J.
    Chen, Li-Tzong
    Uboha, Nataliya Volodymyrivna
    Klumpen, Heinz-Josef
    O'Dwyer, Peter J.
    Li, Daneng
    Morizane, Chigusa
    Huang, Jerry
    Bridgewater, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [37] APERT SYNDROME RESULTS FROM LOCALIZED MUTATIONS OF FGFR2 AND IS ALLELIC WITH CROUZON SYNDROME
    WILKIE, AOM
    SLANEY, SF
    OLDRIDGE, M
    POOLE, MD
    ASHWORTH, GJ
    HOCKLEY, AD
    HAYWARD, RD
    DAVID, DJ
    PULLEYN, LJ
    RUTLAND, P
    MALCOLM, S
    WINTER, RM
    REARDON, W
    NATURE GENETICS, 1995, 9 (02) : 165 - 172
  • [38] Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma
    Ghassan K. Abou-Alfa
    Kristen Bibeau
    Nikolaus Schultz
    Amin Yaqubie
    Brittanie Millang
    Haobo Ren
    Luis Féliz
    Targeted Oncology, 2022, 17 : 517 - 527
  • [39] Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma (vol 51, pg 911, 2021)
    Tsujie, Masanori
    Iwai, Tomohisa
    Kubo, Shoji
    Ura, Takashi
    Hatano, Etsuro
    Sakai, Daisuke
    Takeda, Yutaka
    Kaibori, Masaki
    Kobayashi, Tomoe
    Katanuma, Akio
    Katayose, Yu
    Fukase, Koji
    Sakurai, Naoki
    Ito, Yukiko
    Sato, Fumiya
    Maeda, Atsuyuki
    Asada, Masanori
    Morizane, Chigusa
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (11) : 1694 - 1694
  • [40] Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma
    Abou-Alfa, Ghassan K.
    Bibeau, Kristen
    Schultz, Nikolaus
    Yaqubie, Amin
    Millang, Brittanie
    Ren, Haobo
    Feliz, Luis
    TARGETED ONCOLOGY, 2022, 17 (05) : 517 - 527
12345